Ampila Theraputics (ASX ATX) is starting a phase 2 human trail in pulmonary fibrosis. Might be a good local collaboration. They have FDA orphan status as pulmonary fibrosis is so lacking in any good treatment options.
Ann: POSITIVE TOP-LINE RESULTS FROM PRECLINICAL STUDY IN ARDS, page-9
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
43.0¢ |
Change
0.010(2.38%) |
Mkt cap ! $168.9M | |||
| Open | High | Low | Value | Volume |
| 42.5¢ | 43.5¢ | 42.0¢ | $137.3K | 324.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 10625 | 42.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 43.0¢ | 5500 | 1 |
View Market Depth
| Last trade - 12.07pm 15/07/2025 (20 minute delay) ? |
| PAR (ASX) Chart |